Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nat Rev Cardiol. 2017;14(12): 701-714. 373. Boriani G, Valzania C, Bif M, Diemberger I, Ziacchi M, Martignani C. Asymptomatic lone atrial brillation how can we detect the arrhythmia? Curr Pharmaceut Design. 2015;21(5):659- 666. 374. Pollak WM, Simmons JD, Interian A, et al. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial brillation and utter. Pacing Clin Electrophysiol. 2001;24(4 pt 1): 424-429. 375. Purerfellner H, Gillis AM, Holbrook R, Hettrick DA. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol. 2004;27(7):983- 992. 376. Boriani G, Diemberger I, Ziacchi M, et al. AF burden is important fact or ction? Int J Clin Pract. 2014;68(4):444-452. 377. Boriani G, Padeletti L. Management of atrial brillation in bradyarrhythmias. Nat Rev Cardiol. 2015;12(6):337-349. 378. Zimetbaum P, Waks JW, Ellis ER, Glotzer TV, Passman RS. Role of atrial brillation burden in assessing thromboembolic risk. Circ Arrhythm Electrophysiol. 2014;7(6):1223-1229. 379. Swiryn S, Orlov MV, Benditt DG, et al. Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation. 2016;134(16):1130-1140. 380. Glotzer TV, Hellkamp AS, Zimmerman J, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the 1198 Evidence-Based Medicine [ 1 5 4 # 5 C H E S T N O V E M B E R 2 0 1 8 ] MOde Selection Trial (MOST). Circulation. 2003;107(12):1614- 1619. 381. Capucci A, Santini M, Padeletti L, et al. Monitored atrial brillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial brillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46(10):1913-1920. 382. 